High Sierra Technologies, Inc. (HSTI) is a public company focusing on the cannabis industry. Our long-term goal is to license our intellectual property to key players in the tobacco industry who want to expand into the cannabis market space. Moreover, our patented products and processes position our company to take advantage of a very lucrative and rapidly expanding cannabis market.
The HSTI Advantage
Our intellectual property covers the product, the process whereby we produce our product and any other products created using our product.
Specifically:
- Cannabis products that do not have the pungent odor associated with smoking cannabis.
- Any product made with the first product, such as menthol flavored cannabis. This potentially is huge because menthol cigarettes are 30% of all tobacco sales and the only flavored form of tobacco currently approved by the FDA.
- Our intellectual property covers the actual plant material for smoking. It does not cover the vaping or e-cigarette space. For this reason, we believe that our company will be a prime acquisition target for big tobacco. Given that tobacco companies’ primary focus is making cigarettes, we feel it is highly likely that, in the future, you will be able to buy a pack of cannabis cigarettes at a convenience store. Therefore, if you buy the ones that are flavored or the characteristic cannabis smell has been removed, you will be buying products made using our intellectual property.
Why is this a big deal? Because even when it’s legal, not everyone who uses the product wants to smell like cannabis. They don’t want their clothes to smell like it and they don’t want their cars smelling like it either – for obvious reasons.
What if Cannabis Isn't Legalized Immediately?
What if cannabis isn’t legalized at the federal level in the short term? This won’t adversely affect our company because our patented products and processes can easily be licensed to the producers of these products and licensing is not subject to intra-state restrictions.
In summary, we enjoy a significant advantage over our competition for the following reasons:
- By licensing our intellectual property, we are not subject to banking issues or interstate transportation restrictions like dispensaries.
- Every cannabis producer in the United States, Canada and the European Union will be a potential client.
Our Head Start
Ultimately, when cannabis becomes legalized at the federal level, as is generally believed will happen, the major players in the cigarette tobacco space, like Altria (NYSE: MO) and Reynolds American (NYSE: RAI) will likely start buying up all the small producers and control the market.
They are already buying up cannabis ventures in Canada where we have been issued Canadian Patent Number 3,031,123. Therefore, our company will be a prime buyout candidate
With respect to our company as an acquisition target, Atria recently purchased a 35% stake in an e-cigarette company for $38 billion and e-cigarettes are falling out of favor, which that puts us in a very good position considering our technology is specific for smokable plant material.
At this point, newcomers to the “cannabis gold rush” are at a significant disadvantage. Startups without a unique competitive advantage will have a hard time. Investing in our company allows you into this market without the startup headaches and is potentially the biggest deal on the street.
Legal Protection / Risk
Because we’re licensing intellectual property, our company sidesteps many potential legal issues. We will be able to work across state lines. We can use established banking systems and there is no risk that the Federal regulatory agencies will shut us down. They would have to shut down the entire industry in order to affect us.
We have endeavored to mitigate our risk, by retaining Oliff PLC, in Washington DC, one of the top IP law firms in the country, to prosecute our full utility patent applications, so we are confident in our patent protection. We have already received United States Patent Nos. 10,737,198, 10,835,839, 11,338,222 and 12,458,906 as well as Canadian Patent Number 3,031,123 and European Union Patent Office Patent Number EP3743055. Based on this intellectual property portfolio, our company will be secure in its ability to control a major part of the cannabis industry which is expected to grow to $444.34 billion by 2030 according to Fortune Business Insights.
Business Model / Development
- We are continuing to expand our capabilities for assisting in the production of low odor cannabis products. We will also expand our licensing efforts targeting the cannabis industry for the production of low odor, recreational and medical cannabis.
- Our team includes scientists and seasoned business people. Our marketing expertise and unique technology give us a competitive advantage. For instance, one of the issues in the hemp processing industry is how to remove the residual THC. We are currently developing technology that will convert the residual THC to another cannabinoid, CBN, which is quite valuable.
Public Company / Transparency
Unlike many cannabis startups, this business is already an existing public company. Our short-term goal is to raise $10 million at $1.00 per share, through a private placement, only to accredited investors. This will finance the infrastructure for the expansion of the licensing of our patented technologies for low odor cannabis cigarettes. Our President, Dr. Vincent Lombardi, was an investment banker and a securities trader prior to becoming a scientist. He is all about building the public company to increase value for the shareholders and this is our business vision.